All studies
OphthalmologyPhase II Recruiting
Investigational Treatment for Moderate-to-Severe Dry Eye Disease
Evaluating the safety and symptom relief of an investigational eye drop applied twice daily in adults with moderate-to-severe dry eye disease.
Time commitment
12 weeks
Compensation
Up to $700
Site
PRIME Trials — Northbrook
Who may qualify
Adults 18–85 with moderate-to-severe dry eye disease not adequately managed with artificial tears.
Step 1 of 1
Enroll in this study
Answer a few quick questions below and a study coordinator will call you to confirm eligibility. It takes about a minute and there is no obligation.
Start Enrollment
Investigational Treatment for Moderate-to-Severe Dry Eye Disease
Step 1 of 4Takes ~1 minute
Enter your ZIP code so we can match you to the nearest site.
Prefer to talk now?
Call or text our team and we will walk you through this study.
